{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-098685","form_type":"8-K","ticker":"CATX","cik":"0000728387","company_name":"Perspective Therapeutics, Inc.","filed_at":"2024-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.727966+00:00","generated_at":"2026-05-31T08:45:11.868341+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Perspective Therapeutics CFO Hunt becomes sole principal financial officer; VP Austin departs","bullets":["Mark Austin ceased as VP of Finance, Corporate Controller, Corporate Secretary, and co-principal financial officer on August 16, 2024.","CFO Jonathan Hunt (age 57) now serves as sole principal financial officer and principal accounting officer.","No arrangements, family relationships, or interested transactions exist between Hunt and the company or its officers."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-098685","json":"https://secwatch.observer/filing/0000950170-24-098685.json","markdown":"https://secwatch.observer/filing/0000950170-24-098685.md","text":"https://secwatch.observer/filing/0000950170-24-098685.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/728387/000095017024098685/0000950170-24-098685-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/728387/000095017024098685/catx-20240816.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:45:11.868341+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"504be42051","claim":"Jonathan Hunt changed role as Chief Financial Officer at Perspective Therapeutics, Inc..","evidence_excerpt":"Effective as of the Effective Date, Jonathan Hunt, the Company’s Chief Financial Officer and “co-principal financial officer,” began serving as the Company’s sole “principal financial officer” and “principal accounting officer.”","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024098685/0000950170-24-098685-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"designated"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"8abc50e571","claim":"Mark Austin resigned as Vice President of Finance, Corporate Controller and Corporate Secretary at Perspective Therapeutics, Inc..","evidence_excerpt":"On August 16, 2024 (the “ Effective Date ”), Mark Austin, the Vice President of Finance, Corporate Controller and Corporate Secretary of Perspective Therapeutics, Inc. (the “ Company ”), ceased serving as an executive officer and as the Company’s “co-principal financial officer” and “principal accounting officer.”","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024098685/0000950170-24-098685-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Vice President of Finance, Corporate Controller and Corporate Secretary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}